Canbex Therapeutics Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Holding
- Established
- 2005-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.canbex.co.uk
Clinical Trials
2
Active:1
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Study of VSN16R for the Treatment of Spasticity in Multiple Sclerosis
Phase 2
Completed
- Conditions
- Spasticity in People With Multiple Sclerosis
- Interventions
- Drug: VSN16ROther: Placebo
- First Posted Date
- 2015-09-07
- Last Posted Date
- 2018-03-02
- Lead Sponsor
- Canbex Therapeutics Ltd
- Target Recruit Count
- 160
- Registration Number
- NCT02542787
- Locations
- 🇬🇧
The Neuroscience Research Centre, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom
🇬🇧The Royal London Hospital, London, United Kingdom
🇬🇧The National Hospital for Neurology and Neurosurgery, London, United Kingdom
News
No news found